Researchers modulate the activity of potential therapeutic t

Less than 20% of diagnosed breast cancers are designated "triple-negative," lacking three types of receptors often found in other breast cancer types.

Related Keywords

Benita Katzenellenbogen , John Katzenellenbogen , Emily Henderson , Breast Cancer Research Foundation , National Institutes Of Health , Lab Diagnostics Automation , Mary Landfield Cancer Research Fund , Lab Diagnostics Automation Industry , University Of Illinois Urbana Champaign , Illinois Urbana Champaign , Integrative Physiology , Automation Industry Focus , National Institutes , Breast Cancer , Dancer , Rain , Endocrinology , Estradiol , Estrogen , Gene , Genes , Metastasis , Ortality , Ouse Model , Proliferation , Protein , Eceptor , Research , Humor ,